Monday, 4 April 2016
Innovations in Cell Culture Media Segment Augment Overall Cell Culture Media, Sera, and Reagents Market
The process of growing cells in an artificial laboratory environment is known as cell culture. These cells are used in several industries such as biopharmaceuticals, pharmaceuticals, and biotechnology. In recent years, the demand for cell culture media has created a boom in the overall cell culture media, sera, and reagents market. The rise of the biotechnology industry in Asia has been the underlying reason for the remarkable growth of the media segment in the overall market. Owing to this reason, several big healthcare players are looking at strategic mergers and acquisitions in the region. For example, Corning Life Sciences acquired Mediatech in 2011, while Merck KgaA acquired Millipore, and GE Healthcare acquired PAA.
The global culture media, sera, and reagents market is segmented on the basis of the type of media, sera, and reagents. The types of cell culture media are classical, chemically defined, lysogeny broth (LB), protein-free, serum-free, and specialty. The types of cell culture sera are newborn calf and adult bovine sera, fetal bovine, and others. The types of cell culture reagents are amino acids, albumin, growth factors and cytokines, attachment factors, hormones, and others. Geographically, this market is segmented into Europe, North America, Asia Pacific, Latin America, and Rest of the World.
Media Segment Emerges Above All Others
According to a research report published by Transparency Market Research, the cell culture media segment was the largest segment of the overall cell culture media, sera, and reagents market in 2014. In the coming years, the end users will seek better media that offer robust yields and reproducible results. Technological advancements in cell culture and cell productivity have also encouraged the adoption of smaller processes that are characterized by the usage of single-use equipment. Owing to this reason, there has been a huge demand for media powders and ready-to-use liquid media. Furthermore, demand for media has been shifting from serum-free animal derived, chemically-defined media, and serum-based to serum-sparing. Reports show that adoption of chemically defined media has been exceptionally slow-paced for bioprocessors and media manufacturers.
Asia Pacific to Remain at Forefront with Increasing Outsourcing to Emerging Economies of the Region
In terms of geography, North America held a 40% share in the global cell culture market in 2014. This dominance was attributable to the presence of supportive government policies promoting stem cell and life sciences research. However, Asia Pacific is anticipated to grow at a rapid pace between 2015 and 2023 due to the increasing outsourcing of research to countries such as China, India, Japan, and Australia.
Growing Usage of Cell Culture in Therapeutics and Vital Biomolecules Drives Global Market
According to TMR, the global cell culture media, sera, and reagents market was valued at US$3.7 bn in 2014 and is expected to rise at a CAGR of 7.6% from 2015 to 2023 to reach a figure of US$7.1 bn by 2023. The increasing importance of this technology in areas other than conventional research such as development and production of therapeutics and vital biomolecules is expected to propel this market. The cell culture technology is used in several areas such as bioprocessing and manufacturing of regenerative medicines, biologics, and cell therapy. The only factors hampering the growth of this market are the strict process controls applied to advanced manufacturing capacities and capabilities, ethical concerns over the use of animal sources, and use of transgenic animals and plants.